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Introduction: Human papilloma virus (HPV) causes common warts, laryngeal 
papilloma and genital condylomata and might lead to development of cervical 
cancer. Lactoferrin (LF), a member of the transferrin family, is a bi-globular protein 
and has antiviral activity against HPV-16.  LF is an important player in the defense 
against pathogenic microorganisms and has also shown to have activity against 
several viruses including herpesvirus, adenovirus, rotavirus and poliovirus.  Bovine 
LF has been reported to be a more potent inhibitor of HPV entry than human LF. 
The goal of the present study was to formulate, evaluate and optimize transfersomal 
vesicles as a transdermal drug delivery system for the lactoferrin which assumed to 
be a suitable non-invasive transdermal delivery system for treatment of genital 
warts.  
Methods and Results: Transfersomes have been prepared by two methods of 
reverse phase evaporation and thin film hydration with different ratios of cholesterol: 
lecithin: DOTAP in the presence of SDS or Tween 80. The transferosomes were 
then evaluated regarding size, polydispersity and LF loading.  In vitro release studies 




 and TEM imaging has been performed 
on optimized transferosomal lactoferrin. The optimized transferosomes were found 
to have 100 nm sizes with good PDI and encapsulation efficiency of 91% for 
lactoferrin as well as sustained release of lactoferrin during 24 hours. It was shown 
that unlike lactoferinn which should be stored in cold temperature, transferosomal 
lactoferrin would be stable in cool conditions. 
Conclusions: 
The elastic vesicular systems like transferosomes are one of the most controversial 
methods for transdermal delivery of active substances specially macromolecules and 
proteins. It was found that transferosomes would be ideal nano carriers with high 
loading efficiency and size uniformity as well as improving stability of lactoferrin. 
Further study is needed to investigate its efficacy in treatment of HPV caused genital 
warts and its viral inhibitory function. 
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